Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report

Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report

Abstract Backround We describe one of the first cases of a Posterior reversible encephalopathy syndrome (PRES) under tocilizumab as treatment of Giant cell arteritis (GCA). Case presentation A 65-year-old female with known GCA and treatment with Tocilizumab (TCZ) developed a convulsive epileptic sei...

Full description

Bibliographic Details
Main Authors: Michaela Butryn, Sabine Mewes, Eugen Feist, Oliver Beuing, Christian Müller, Jens Neumann
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Neurology
Subjects:
Tocilizumab
Posterior reversible encephalopathy syndrome
Giant cell arteritis
Online Access:https://doi.org/10.1186/s12883-021-02231-7

Internet

https://doi.org/10.1186/s12883-021-02231-7

Similar Items